Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Glaxosmithkline (GSK)

Price 1,392.20p on 26-05-2023 at 17:22:01
Change 7.60p 0.55%
Buy 1,396.20p
Sell 1,395.80p
Buy / Sell GSK Shares
Last Trade: Unknown 57,320.00 at 1,392.089p
Day's Volume: 9,735,135
Last Close: 1,392.20p
Open: 1,384.00p
ISIN: GB00BN7SWP63
Day's Range 1,380.40p - 1,400.60p
52wk Range: 1,283.20p - 1,824.40p
Market Capitalisation: £57,010m
VWAP: 1,386.56621p
Shares in Issue: 4,095m

Recent Trades History Glaxosmithkline (GSK)

Buy/Sell Volume Trade Prc Trade Type Trade Time
Unknown* 57,320 1,392.089p Ordinary
Currency Conversion
OTC Trade
17:22:00 - 26-May-23
Unknown* 380,000 1,384.00p Ordinary
OTC Trade
17:03:06 - 26-May-23
Unknown* 380,000 1,384.00p Ordinary
OTC Trade
17:01:25 - 26-May-23
Unknown* 403 1,391.643p Ordinary
Currency Conversion
OTC Trade
16:58:32 - 26-May-23
Unknown* 267 1,393.12749p Ordinary
Currency Conversion
OTC Trade
16:58:29 - 26-May-23
Unknown* 85 1,392.243p Ordinary
Currency Conversion
OTC Trade
16:52:35 - 26-May-23
Unknown* 21,634 1,392.20p Ordinary
Currency Conversion
OTC Trade
16:51:37 - 26-May-23
Unknown* 21,294 1,392.20p Ordinary
Currency Conversion
OTC Trade
16:51:37 - 26-May-23
Unknown* 195 1,392.20p Ordinary
Currency Conversion
OTC Trade
16:51:25 - 26-May-23
Unknown* 982,879 1,384.00p Ordinary
OTC Trade
15:43:03 - 26-May-23

Share Price History for Glaxosmithkline

Time period:
to
Date Open High Low Close Volume

Share News for Glaxosmithkline

IN BRIEF: Destiny Pharma picks interim CEO as Clark makes quick exit

25th May 2023 10:42

Destiny Pharma PLC - Brighton, England-based clinical-stage biotechnology company focused on preventing life-threatening infections - Chief Executive Officer Neil Clark steps down immediately "to pursue new challenges". Clark will "support [Destiny] for a limited period to ensure an orderly handover." Non-Executive Director Debra Barker will serve as interim CEO until Destiny appoints a permanent replacement. Barker has held "key roles" at Novartis AG and Polyphor AG, now named Spexis AG. She also has previously worked at Roche Holding AG, Polyneuron Pharmaceuticals AG and GSK PLC. Read More

LONDON MARKET CLOSE: Sterling slides after weak UK GDP print

12th May 2023 16:53

(Alliance News) - Stocks in London ended the week broadly higher on Friday, with strong performances from blue-chips Beazley and GSK helping to offset weak economic growth data for the UK economy. Read More

LONDON MARKET MIDDAY: FTSE 100 outperforms as Beazley, GSK shine

12th May 2023 12:10

(Alliance News) - Stock prices in London were mixed at midday on Friday as investors digested a weak GDP reading for the UK, a day after the Bank of England took the country's interest rates up to a 15-year-high. Read More

GSK hails 5-in-1 meningococcal ABCWY vaccine candidate trial data

12th May 2023 10:08

(Alliance News) - GSK PLC on Friday reported positive preliminary results from a phase 3 trial regarding its 5-in-1 meningococcal ABCWY vaccine candidate. Read More

TOP NEWS: GSK welcomes legal ruling in Canada; sells Haleon shares

12th May 2023 08:26

(Alliance News) - GSK PLC on Friday welcomed a legal ruling in Canada that threw out a proposed class action made on behalf of users of a heartburn drug. Read More

FTSE 100 Latest
Value7,627.20
Change56.33

Login to your account

Forgot Password?

Not Registered